226 related articles for article (PubMed ID: 19548905)
1. The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission.
Groot E; Fijnheer R; Sebastian SA; de Groot PG; Lenting PJ
J Thromb Haemost; 2009 Jun; 7(6):962-9. PubMed ID: 19548905
[TBL] [Abstract][Full Text] [Related]
2. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
[TBL] [Abstract][Full Text] [Related]
3. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
Budde U; Schneppenheim R
Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
[TBL] [Abstract][Full Text] [Related]
4. Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood.
Tsai HM; Sarode R; Downes KA
Thromb Res; 2002 Nov; 108(2-3):121-5. PubMed ID: 12590947
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.
Crawley JT; Scully MA
Hematology Am Soc Hematol Educ Program; 2013; 2013():292-9. PubMed ID: 24319194
[TBL] [Abstract][Full Text] [Related]
6. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
[TBL] [Abstract][Full Text] [Related]
7. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
8. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.
Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F
Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507
[TBL] [Abstract][Full Text] [Related]
9. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
[TBL] [Abstract][Full Text] [Related]
10. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.
Hulstein JJ; de Groot PG; Silence K; Veyradier A; Fijnheer R; Lenting PJ
Blood; 2005 Nov; 106(9):3035-42. PubMed ID: 16014562
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
12. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
14. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.
Hori Y; Hayakawa M; Isonishi A; Soejima K; Matsumoto M; Fujimura Y
Transfusion; 2013 Dec; 53(12):3192-202. PubMed ID: 23560518
[TBL] [Abstract][Full Text] [Related]
15. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Lämmle B
Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
[TBL] [Abstract][Full Text] [Related]
16. Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: a short review and update.
Markham-Lee Z; Morgan NV; Emsley J
Platelets; 2023 Dec; 34(1):2138306. PubMed ID: 36281781
[TBL] [Abstract][Full Text] [Related]
17. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
[TBL] [Abstract][Full Text] [Related]
18. Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.
Deforche L; Tersteeg C; Roose E; Vandenbulcke A; Vandeputte N; Pareyn I; De Cock E; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
PLoS One; 2016; 11(8):e0160388. PubMed ID: 27479501
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
[TBL] [Abstract][Full Text] [Related]
20. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.
Kato S; Matsumoto M; Matsuyama T; Isonishi A; Hiura H; Fujimura Y
Transfusion; 2006 Aug; 46(8):1444-52. PubMed ID: 16934083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
